Navigation Links
Traveling stem cell show continues state tour

Madison, Wis. - A kind of traveling road show is making its way around Wisconsin to educate people about one of the most controversial areas of scientific research - embryonic stem cell research - and its presenters believe even the skeptics are walking away a little less skeptical.

The presentations by Tom Still, president of the
Full article >>> uld come later.

Things like transplantation therapies are way down the road because we have to understand this other stuff first, she said.

While the research is still in its infancy, Still said the sale of stem cell products worldwide reached $16.4 million in 2006, it's expected to more than double to $35 million in 2007, and then experience 50 percent annual growth rates in sub......

Full article >>> James Thomson used when he developed a method of deriving stem cells from embryos, and two more since. One reason for this is that embryonic stem cells have the ability to reproduce indefinitely in culture, making it possible to obtain large amounts for scientific study.

Another factor, Carlson said, is that the university has developed a cell culture system in which stem cell lines can b......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 04/02/07


Related biology technology :

1. Traveling the I-Q Corridor: Upper Midwest technology future is bright
2. AT&T - BellSouth merger: Revestiture continues
3. Madison biotech continues its climb
4. Transition continues to impact Third Wave financials
5. Line between big pharma, big biotech continues to blur
6. Brady continues growth through Asian acquisition
7. Wisconsin giant continues to dominate the health care IT market
8. API Software continues expansion
9. Third Wave continues molecular diagnostic focus with new CEO
10. Corona Optical Systems continues to excite investors
11. Web-based reporting credited with states top healthcare ranking
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... Oregon (PRWEB) , ... December 08, 2016 , ... ... and the FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI ... not require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... packaging for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. ... bioprocess media products engineered to radically streamline culture processes, minimize processing time, ...
(Date:12/8/2016)... 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a ... plans to commercialize innovative therapeutics for patients with ... were approved for trading on the OTCQX U.S. ... OTCQX, effective today, under the ticker symbol "HPPI." ... companies must meet high financial standards, follow best ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented today ... clinical trial for its lead drug candidate, AC0010, at the World Conference on ... to determine the safety, antitumor activity, and recommended phase II dosage of AC0010 ...
Breaking Biology Technology:
(Date:12/7/2016)... According to a new market research report "Emotion Detection ... Voice Recognition), Service, Application Area, End User, And Region - Global Forecast to ... 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a Compound ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... LONDON , Dec. 7, 2016   Avanade ... most successful Formula One teams in history, exploit biometric ... pit stop performance and maintain the competitive edge against ... in 2016. Avanade has worked with ... a range of biometric data (heart rate, breathing rate, ...
(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. ... has priced an offering of €500.0 million principal amount of ... principal amount of its 2.425% senior unsecured notes due 2026. ... to occur on December 13, 2016, subject to the satisfaction of ... annual basis. The Company intends ...
Breaking Biology News(10 mins):